Top Abstract Purchase Related
Home
>
Node
>
Subnode

Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010

Chang, B.W.; Siccion, E.; Saif, M.Wasif.

JOP Journal of the pancreas 11(4): 313-316

2010

ISSN/ISBN: 1590-8577
PMID: 20601800
Document Number: 640018
Pancreatic cancer is the 4th leading cancer cause mortality in both men and women. Pancreatic cancer is usually diagnosed in the advanced setting, and only 10-15% of patients present with operable disease. About 25% are locally advanced and unresectable and the rest are metastatic. Studies presented at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted both current treatment options and promising novel therapeutic agents and approaches.

Document emailed within 1 workday
Secure & encrypted payments

Li, J.; Merl, M.Yee.; Chabot, J.; Saif, M.Wasif. 2010: Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010 JOP: Journal of the pancreas 11(4): 310-312
Kim, R.; Chabot, J.; Saif, M.Wasif. 2011: Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011 JOP: Journal of the pancreas 12(4): 362-363
Li, J.; Merl, M.Yee.; Saif, M.Wasif. 2010: Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010 JOP: Journal of the pancreas 11(2): 151-153
Bonetti, A.; Cascinu, S.; Falcone, A.; Zaniboni, A. 2006: ASCO 2006 Annual Meeting, Atlanta, June 2-6, 2006. Focus on gastrointestinal tumors Tumori 92(4): Suppl. 10-43
Yu, E.Y. 2011: Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual Meeting Clinical Advances in Hematology and Oncology: H&o 9(8 Suppl. 21): 1-24
Kalra, P.R.; Roberts, P.R.; Anker, S.D. 2003: 52nd annual scientific sessions of the ACC: highlights in CHF research. March 30-April 2, 2003, Chicago, IL, USA Heart failure monitor 4(1): 34-36
Chan, D.; Cleverley, J. 2006: American Society of Clinical Oncology--42nd annual meeting. Current approaches to lung cancer therapy. 2-6 June 2006, Atlanta, GA, USA IDrugs: the investigational drugs journal 9(8): 523-525
Chagpar, A.B. 2007: Insights into the management of locally advanced, inflammatory, and metastatic breast cancer: highlights from the 2007 Louisville Breast Cancer Update Journal of the Kentucky Medical Association 105(11): 559-560
Chen, R. 2012: Highlights in lymphoma from the 2012 European Hematology Association Annual Meeting Clinical Advances in Hematology and Oncology: H&o 10(9 Suppl. 16): 1-24
Beluffi, G. 1993: Bone dysplasia Society--First meeting. Bigler Auditorium--the Children's Memorial Hospital (Chicago, Illinois, June 17-19, 1993) La Radiologia Medica 86(5): 744-745
Czito, B.G.; Willett, C.G.; Clark, J.W.; Fernandez Del Castillo, C. 2000: Current perspectives on locally advanced pancreatic cancer Oncology 14(11): 1535-45; Discussion 1546 1549-52
Kneller, S. 2005: Monoclonal Antibodies -- Visiongain's Second Annual Meeting. 29-30 June 2005, London, UK IDrugs: the investigational drugs journal 8(9): 713-715
Dimou, A.T.; Syrigos, K.N.; Saif, M.Wasif. 2011: Novel agents in the management of pancreatic adenocarcinoma: phase I studies. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011 JOP: Journal of the pancreas 12(2): 114-116
Russo, S.M.; Ove, R.; Saif, M.Wasif. 2011: Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011 JOP: Journal of the pancreas 12(2): 92-95
Baba, H.; Suzuki, Y.; Ema, T.; Kawakami, M.; Nakanishi, C.; Hashimoto, T.; Arai, T.; Matsumoto, G.; Tsuruta, K.; Okamoto, A.; Karasawa, K. 2005: Gemcitabine concurrent with radiation for locally advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1730-1732
Mazucco, R. 2001: American Urological Association - 96th Annual Meeting. 2-7 June 2001, Anaheim, CA, USA IDrugs: the investigational drugs journal 4(8): 892-895
Saif, M.Wasif. 2008: Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008 JOP: Journal of the pancreas 9(2): 91-98
Mukhtar, M. 1998: Neuroscience of HIV Infection--Eighth International Meeting. Basic research and clinical frontiers. 3-6 June 1998, Northwestern University Medical School, Chicago, Illinois, USA IDrugs: the investigational drugs journal 1(3): 292-293
McGowran, M. 2001: American Society of Gene Therapy - Fourth Annual Meeting. 30 May-3 June 2001, Seattle, WA, USA IDrugs: the investigational drugs journal 4(8): 896-900
Taoka, H.; Hirano, H.; Mitsui, Y.; Umino, W.; Nobuoka, Y.; Yamashita, M.; Tanigawa, K.; Yoshimine, S.; Imai, T.; Kadowaki, S.; Miyashita, K.; Ikuma, H.; Nakamura, T.; Murata, T. 2004: Adjuvant chemotherapy for unresectable locally advanced pancreatic cancer in light of its characteristics Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1365-1370